Vasopressin Dose and Mechanism Sepsis — FRCA Final MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — 0.03 units/min (up to 0.03 units/min) – V1 receptor agonist causing vasoconstriction independently of adrenergic receptors
Vasopressin (arginine vasopressin/ADH) is used in septic shock at a FIXED dose of up to 0.03 units/min (not titrated) as an adjunct to noradrenaline. It acts on V1 receptors on vascular smooth muscle, causing vasoconstriction via a non-adrenergic mechanism (independent of catecholamine receptors, which may be downregulated in prolonged septic shock). The VASST trial (2008) showed it was non-inferior to noradrenaline as second-line and may reduce noradrenaline requirements. It should NOT be used as a single vasopressor. V2 receptor effects cause water retention (antidiuretic effect).
Reference: SSC – 2021 – Sepsis guidelines; Russell JA et al – 2008 – VASST trial